Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Biomarker-enhanced triage in respiratory infections: a proof-of-concept feasibility trial.
Albrich WC, Rüegger K, Dusemund F, Schuetz P, Arici B, Litke A, Blum CA, Bossart R, Regez K, Schild U, Guglielmetti M, Conca A, Schäfer P, Schubert M, de Geest S, Reutlinger B, Irani S, Bürgi U, Huber A, Müller B. Albrich WC, et al. Among authors: dusemund f. Eur Respir J. 2013 Oct;42(4):1064-75. doi: 10.1183/09031936.00113612. Epub 2013 Jan 24. Eur Respir J. 2013. PMID: 23349444 Free PMC article. Clinical Trial.
Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: derivation of a clinical algorithm.
Albrich WC, Dusemund F, Rüegger K, Christ-Crain M, Zimmerli W, Bregenzer T, Irani S, Buergi U, Reutlinger B, Mueller B, Schuetz P. Albrich WC, et al. Among authors: dusemund f. BMC Infect Dis. 2011 May 3;11:112. doi: 10.1186/1471-2334-11-112. BMC Infect Dis. 2011. PMID: 21539743 Free PMC article. Clinical Trial.
Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract infections in "real life": an international, multicenter poststudy survey (ProREAL).
Albrich WC, Dusemund F, Bucher B, Meyer S, Thomann R, Kühn F, Bassetti S, Sprenger M, Bachli E, Sigrist T, Schwietert M, Amin D, Hausfater P, Carre E, Gaillat J, Schuetz P, Regez K, Bossart R, Schild U, Mueller B; ProREAL Study Team. Albrich WC, et al. Among authors: dusemund f. Arch Intern Med. 2012 May 14;172(9):715-22. doi: 10.1001/archinternmed.2012.770. Arch Intern Med. 2012. PMID: 22782201
Effectiveness of a procalcitonin algorithm to guide antibiotic therapy in respiratory tract infections outside of study conditions: a post-study survey.
Schuetz P, Batschwaroff M, Dusemund F, Albrich W, Bürgi U, Maurer M, Brutsche M, Huber AR, Müller B. Schuetz P, et al. Among authors: dusemund f. Eur J Clin Microbiol Infect Dis. 2010 Mar;29(3):269-77. doi: 10.1007/s10096-009-0851-0. Epub 2009 Dec 29. Eur J Clin Microbiol Infect Dis. 2010. PMID: 20039090 Clinical Trial.
Optimised patient transfer using an innovative multidisciplinary assessment in Kanton Aargau (OPTIMA I): an observational survey in lower respiratory tract infections.
Albrich WC, Rüegger K, Dusemund F, Bossart R, Regez K, Schild U, Conca A, Schuetz P, Sigrist T, Huber A, Reutlinger B, Müller B. Albrich WC, et al. Among authors: dusemund f. Swiss Med Wkly. 2011 Jul 30;141:w13237. doi: 10.4414/smw.2011.13237. eCollection 2011. Swiss Med Wkly. 2011. PMID: 21805408 Free article.
Influence of procalcitonin on decision to start antibiotic treatment in patients with a lower respiratory tract infection: insight from the observational multicentric ProREAL surveillance.
Dusemund F, Bucher B, Meyer S, Thomann R, Kühn F, Bassetti S, Sprenger M, Baechli E, Sigrist T, Schwietert M, Amin D, Hausfater P, Carre E, Schuetz P, Gaillat J, Regez K, Bossart R, Schild U, Müller B, Albrich WC; ProREAL Study Team. Dusemund F, et al. Eur J Clin Microbiol Infect Dis. 2013 Jan;32(1):51-60. doi: 10.1007/s10096-012-1713-8. Epub 2012 Aug 12. Eur J Clin Microbiol Infect Dis. 2013. PMID: 22886090
16 results